Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q1 2025 · 10-Q
Revenue$18.91M$18.91M−16.6% vs Q1 2024 Net Income-$1.52M-$1.52MN/M vs Q1 2024 EPS Diluted-$0.04-$0.04N/M vs Q1 2024 Gross Profit$3,042,000−0.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flow-$3,487,000N/M Free Cash Flowderived-$3,550,000N/M Margins · derivedGross margin16.1%+2.6 pt vs Q1 2024
Operating margin-7.2%−1.4 pt vs Q1 2024
Net margin-8.0%−0.4 pt vs Q1 2024
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end